Comparing the current results to its competitors, American Oncology Network Inc reported Revenue increase in the 4 quarter 2024 by 51.42 % year on year. The sales growth was above American Oncology Network Inc 's competitors' average revenue growth of 8.89 %, achieved in the same quarter.
American Oncology Network Inc achieved net profit of $2.41 millions compared to a net loss of $-32.41 millions recorded in the same quarter a year ago.
American Oncology Network Inc 's Comment on Competition and Industry Peers
The company operates within the competitive U.S. healthcare industry, contending with national, regional, and local healthcare providers for patients and physicians. Its primary competitors include traditional community oncology physician practices, local and national health systems, and national oncology management service organizations such as US Oncology Network, Inc. and OneOncology, Inc. Both US Oncology Network, Inc. and OneOncology, Inc. provide nationwide oncology management platforms that include diagnostics, specialty pharmacies, and clinical laboratories. The company distinguishes itself through a management model that grants network physicians a high level of autonomy after joining as employed physicians. Competitors may possess greater recognition, financial resources, larger facilities, or different programs, potentially making them more attractive to patients and referral sources. Key competitive factors in the industry include patient experience, quality of care, health outcomes, total cost of care, brand identity, and trust in the brand.
Due to outstanding performance in Overall company, revenue grew by 51.42 % American Oncology Network Inc improved its market share, to approximately 0.26 %.
June 4, 2024
Pioneering Advances in Oncology: American Oncology Network Unveils Groundbreaking Research at ASCO 2024 Annual Meeting The Annual Meeting of the American Society of Clinical Oncology (ASCO) serves as a confluence for the world s leading oncologists, researchers, and healthcare professionals. This year, the American Oncology Network (AON) stood at the forefront, showcasing their latest cancer research findings and contributing significantly to the global dialogue on cancer treatment and management.AON physicians and leaders presented a diverse array of studies, each exemplifying the network s commitment to innovation and excellence in oncology. The meeting provided a prestigious platform for AON to share thei...
May 15, 2024
In a groundbreaking development, the American Oncology Network (AON) Central Lab has pioneered the use of cutting-edge AI software to revolutionize karyogram segmentation, significantly reducing analysis time in cancer diagnosis. This remarkable achievement positions the AON Central Lab as the global frontrunner in leveraging artificial intelligence to advance oncology diagnostics and improve patient outcomes.Karyogram segmentation plays a pivotal role in identifying chromosomal abnormalities that underlie various types of cancer. Traditionally, this process has been time-consuming and prone to human error. However, with the integration of AI software, the AON Central Lab has successfully transformed the lan...
April 4, 2024
In a notable move to elevate cancer care delivery in Central Georgia, Central Georgia Cancer Care has announced a strategic partnership with the American Oncology Network (AON). As one of the nation s fastest-growing networks, AON offers community-based oncology practices resources and in-depth expertise that will help to strengthen and refine the patient care and services provided by Central Georgia Cancer Care. Central Georgia Cancer Care s decision to join hands with the American Oncology Network comes as a powerful response to the continually evolving healthcare needs of the central Georgia community. By leveraging the network’s vast resources and expertise, Central Georgia Cancer Care aims to uphold i...
April 3, 2024
Escalating cancer incidence and mortality rates command collaborative efforts to enrich global cancer care. These efforts take a transformative leap forward with the recent partnership between American Oncology Network (AON), one of the leading national networks of community oncology practices and, Hawaii Cancer Care (HCC), a foundational healthcare entity in Hawaii. This collaboration is geared towards revolutionizing cancer care on the islands and to a broader global community.Specialists at HCC are now part of the AON family, and are pleased to welcome AON s wide-ranging oncology portfolio into Hawaii. AON s commitment to providing top-tier cancer treatment aligns with HCC s mission to extend exemplary ca...
Publicly Traded Peers of American Oncology Network Inc
Accuray Incorporated Share Performance
-84.15%
One Year
Accuray Incorporated
Profile
Accuray Incorporated is a medical technology company that focuses on the development and sale of radiation therapy systems. Their business model revolves around providing advanced and precise treatment options to cancer patients by combining robotics and imaging technologies. By delivering innovative solutions, Accuray aims to improve patient outcomes and establish partnerships with healthcare providers worldwide.
Cardinal Health Inc operates as a prominent integrated healthcare services provider in the United States, specializing in the distribution of pharmaceuticals and medical products to various healthcare settings, including retail pharmacies and hospitals. The company enhances healthcare efficiency through a range of services such as inventory management, medication therapy management, and data analytics solutions aimed at optimizing operations and improving patient care.
Edap Tms Sa's business model revolves around providing minimally invasive medical devices and solutions for the treatment of urological diseases, specifically focusing on advanced ultrasound technologies for the diagnosis and treatment of prostate cancer and kidney stones.
Fonar Corporation operates as a medical technology company that specializes in the development, production, and marketing of magnetic resonance imaging (MRI) scanners. Their business model revolves around selling and servicing their proprietary MRI machines to healthcare facilities worldwide. They generate revenue through the sales of these scanners, as well as by providing additional services such as maintenance and support to their customers.
HCA Healthcare Inc operates a vast network of hospitals and healthcare facilities, providing a wide range of medical services including emergency care, surgical procedures, and specialized treatments. The company emphasizes the integration of advanced technology and clinical excellence to enhance patient outcomes while maintaining cost efficiency. HCA generates revenue primarily through patient care services, insurance reimbursements, and partnerships with various healthcare stakeholders.
Sources:
American Oncology Network Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on American Oncology Network Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
